Rockwell Medical (RMTI) Free Cash Flow (QoQ) (2010 - 2026)
Rockwell Medical (RMTI) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 28.15 Mn | 4.26 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.88% |
| Dec 31, 2025 | 237.05% |
| Sep 30, 2025 | -191.64% |
| Jun 30, 2025 | 148.54% |
| Mar 31, 2025 | -855.32% |
| Dec 31, 2024 | -88.49% |
| Sep 30, 2024 | 253.29% |
| Jun 30, 2024 | 145.89% |
| Mar 31, 2024 | -2,829.07% |
| Dec 31, 2023 | 97.72% |
| Sep 30, 2023 | -107.09% |
| Jun 30, 2023 | 54.74% |
| Mar 31, 2023 | -923.16% |
| Dec 31, 2022 | 61.55% |
| Sep 30, 2022 | 82.84% |
| Jun 30, 2022 | 39.48% |
| Mar 31, 2022 | -7.66% |
| Dec 31, 2021 | -26.91% |
| Sep 30, 2021 | -39.01% |
| Jun 30, 2021 | 58.66% |